Lipid signaling in embryo implantation.
A reciprocal interaction between the implantation-competent blastocyst and the receptive uterus is required for successful implantation. Although various molecular pathways are known to participate in this cross-talk, a comprehensive understanding of the implantation process is still missing. Gene expression studies and genetically engineered mouse models have provided evidence that lipid mediators serve as important signaling molecules in coordinating the series of events during early pregnancy including preimplantation embryo formation and development, implantation and postimplantation growth. This review focuses on the roles of two groups of lipid mediators, prostaglandins (PGs) and endocannabinoids, during early pregnancy. Our laboratory has shown that while PGs generated by the cPLA2-cyclooxygenase (COX) system are essential to ovulation, fertilization, and implantation, endocannabinoids are important for synchronizing preimplantation embryo development with uterine receptivity for implantation. A better understanding of these molecular signaling pathways is hoped to generate new strategies to correct implantation failure and improve pregnancy rates in women.
Wang
Haibin
H
Department of Pediatrics, Division of Reproductive & Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Dey
Sudhansu K
SK
D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism; D010064:Embryo Implantation; D005260:Female; D005306:Fertilization; D017403:In Situ Hybridization; D050356:Lipid Metabolism; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D010060:Ovulation; D010741:Phospholipases A / Q000378:metabolism*; D011247:Pregnancy; D011270:Pregnancy, Animal; D011453:Prostaglandins / Q000378:metabolism; D015398:Signal Transduction; D013997:Time Factors; D014599:Uterus / Q000378:metabolism
D063385:Cannabinoid Receptor Modulators; D011453:Prostaglandins; D010741:Phospholipases A